Related Experiment Videos
TIP, a T-cell factor identified using high-throughput screening increases survival in a graft-versus-host disease
Michele Fiscella1, James W Perry, Baiqin Teng
1Department of Preclinical Discovery, Human Genome Sciences, Inc., Rockville, MD 20850, USA.
Nature Biotechnology
|February 25, 2003
Summary
Researchers discovered T cell immunomodulatory protein (TIP), a novel factor enhancing T-cell responses and protecting against graft-versus-host disease. This highlights the power of combining bioinformatics with high-throughput screening for new discoveries in immunology.
Area of Science:
- Immunology
- Bioinformatics
- Genomics
Background:
- Identifying novel factors in T-cell biology is crucial for understanding immune responses.
- Existing methods for discovering immunomodulatory proteins are often limited in scope and efficiency.
Purpose of the Study:
- To identify novel proteins involved in T-cell biology using a combination of bioinformatics and high-throughput screening.
- To characterize the function and potential therapeutic applications of newly discovered T-cell factors.
Main Methods:
- Generated a cDNA library of predicted secreted and transmembrane proteins using bioinformatic algorithms.
- Utilized high-throughput cell-based screening assays with primary T cells and T-cell lines.
- Analyzed protein function through in vitro cytokine secretion assays and in vivo disease models.
Main Results:
- Discovered T cell immunomodulatory protein (TIP), a novel protein without known homology.
- TIP treatment of T cells induced secretion of IFN-gamma, TNF-alpha, and IL-10 in vitro.
- TIP demonstrated a protective effect in a mouse model of acute graft-versus-host disease (GVHD) in vivo.
Conclusions:
- The integrated approach of functional genomics and high-throughput screening is effective for discovering novel immunomodulatory proteins.
- TIP represents a promising candidate for therapeutic intervention in T-cell mediated diseases.
- This study expands the toolkit for identifying and characterizing new players in T-cell immunology.